Clinical trial
Efficacy and Safety of Expandable Spacer in the Treatment of Degenerative Disc Disease Using the Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgical Approach
NCT02075554 is registered in ClinicalTrials.gov with Globus Medical Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Expandable Spacer in the Treatment of Degenerative Disc Disease Using the Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgical Approach
- Lead sponsor
- Globus Medical Inc
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2012
- Completion date
- February 28, 2017
- Enrollment
- 58 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
degenerative disc disease